Language selection

Search

2008-03-13 - Male - 9 Years old

303901

Adverse reaction report number 303901
Latest AER version number 1
Market authorization holder AER number SPV1200800457
Initial received date 2008-03-13
Latest received date 2008-05-28
Age 9 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral10 Milligram1 every 1 Day(s)1 Year(s)Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral15 Milligram1 every 1 Day(s)1 Month(s)Attention deficit/hyperactivity disorder
ADDERALL XRSuspectOral15 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral5 Milligram1 every 1 Day(s)5 Month(s)Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug ineffective
Date modified: